1.Bagert J, Mitchener M, Patriotis A, Dul B, Wojcik F, Nacev B, Feng L, Allis D, Muir T. Oncohistone mutations enhance chromatin remodeling and alter cell fates. Nat Chem Biol. 2021;17(4):403–411. PMCID: PMC8174649 Reference Link
1.Burton A, Haugbro M, Gates L, Bagert J, Allis D, Muir T. In situ chromatin interactomics using a chemical bait and trap approach. Nat Chem. 2020;12(6):520–527. PMCID: PMC7331920 Reference Link
1.Wan L, Chong S, Xuan F, Liang A, Cui X, Gates L, Carroll T, Li Y, Feng L, Chen G, Wang S-P, Ortiz M, Daley S, Wang X, Xuan H, Kentsis A, Muir T, Roeder R, Li H, Li W, Tjian R, Wen H, Allis D. Impaired cell fate through gain-of-function mutations in a chromatin reader. Nature. 2020;577(7788):121–126. PMCID: PMC7061414 Reference Link
1.Diehl K, Ge E, Weinberg D, Jani K, Allis D, Muir T. PRC2 engages a bivalent H3K27M-H3K27me3 dinucleosome inhibitor. Proc Natl Acad Sci U S A. 2019;116(44):22152–22157. PMCID: PMC6825254 Reference Link
1.Nacev B, Feng L, Bagert J, Lemiesz A, Gao J, Soshnev A, Kundra R, Schultz N, Muir T, Allis D. The expanding landscape of ’oncohistone’ mutations in human cancers. Nature. 2019;567(7749):473–478. PMCID: PMC6512987 Reference Link
1.Dann G, Liszczak G, Bagert J, Müller M, Nguyen U, Wojcik F, Brown Z, Bos J, Panchenko T, Pihl R, Pollock S, Diehl K, Allis D, Muir T. ISWI chromatin remodellers sense nucleosome modifications to determine substrate preference. Nature. 2017;548(7669):607–611. PMCID: PMC5777669 Reference Link
1.Lu C, Jain S, Hoelper D, Bechet D, Molden R, Ran L, Murphy D, Venneti S, Hameed M, Pawel B, Wunder J, Dickson B, Lundgren S, Jani K, De Jay N, Papillon-Cavanagh S, Andrulis I, Sawyer S, Grynspan D, Turcotte R, Nadaf J, Fahiminiyah S, Muir T, Majewski J, Thompson C, Chi P, Garcia B, Allis D, Jabado N, Lewis P. Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape. Science. 2016;352(6287):844–9. PMCID: PMC4928577 Reference Link
